📈 Jumpstart Signal Watchlist — August 26, 2026

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 Current $13.23 is 6% below 3yr high $14.14 · ⏳ SMA200 $6.32 (current price $13.23 is above) · 💰 Market Cap $747M
- PAYS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 450% (>20%); Revenue growth 48% (>15%); ROE 26% (>15%); Low LT D/E 0.06 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.4%)
- 🔔 Strong above EMA50 (26.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ Paysign (NASDAQ:PAYS) Hits New 12-Month High — MarketBeat.
🤖 The piece highlights a new 52-week high, strong second-quarter results, and a raised FY 2026 outlook. It also cites bullish analyst ratings and price targets, which is constructive for the stock.
✅ Paysign (NASDAQ:PAYS) Sets New 1-Year High - Here's Why — MarketBeat.
🤖 This article frames the move to a new 52-week high as being driven by earnings beats, raised guidance, and favorable analyst coverage. The combination of strong operating performance and positive Street sentiment is bullish.
⚪️ Paysign (NASDAQ:PAYS) Shares Down 5.3% — MarketBeat.
🤖 The article focuses on a same-day stock move rather than new fundamentals, but it notes Paysign recently beat quarterly estimates and raised fiscal 2026 guidance. That underlying earnings and outlook update is supportive, though the headline price action itself was negative.
⚪️ Paysign (NASDAQ:PAYS) Stock Rating Lowered by Wall Street Zen — MarketBeat.
🤖 The downgrade from strong-buy to buy is modest and does not change the broader bullish analyst consensus. Because the same report also cites strong earnings, it is best read as mildly mixed rather than clearly negative.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: MeiraGTx Holdings plc is a clinical-stage genetic medicines company that develops gene therapies and other genetic medicine platforms for both rare and more common diseases. Its work includes programs in eye diseases, Parkinson’s disease, and radiation-induced dry mouth, along with its riboswitch technology for controlled delivery of biologic therapies.
- 🎯 Current $14.56 is 3% below 3yr high $14.97 · ⏳ SMA200 $9.51 (current price $14.56 is above) · 💰 Market Cap $1.4B
- MGTX shows decent technicals supported by positive sentiment.

💎 Quality (Q): 38/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 456% (>20%); PEG ratio 0.04 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (6.9%)
- 🔔 Strong above EMA50 (15.2%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive.
✅ MeiraGTx Reports Second Quarter 2026 Financial and Operational Results — GlobeNewswire.
🤖 MeiraGTx reported a sharp Q2 beat, including positive three-year data for AAV2-hAQP1, FDA Breakthrough Therapy Designation, and the acquisition of global rights to bota-vec. The company also highlighted major financing support, which improves execution capacity despite some dilution risk.
✅ MeiraGTx (NASDAQ:MGTX) Given New $27.00 Price Target at Royal Bank Of Canada — MarketBeat.
🤖 RBC raised its price target to $27 and kept an outperform rating, signaling stronger analyst confidence in MGTX after the company’s earnings beat and pipeline updates. Higher targets and favorable sentiment are generally supportive for the stock.
⚪️ MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule — Yahoo Finance.
🤖 The company announced equity awards for a new employee under its inducement plan. This is a routine compensation event and has little direct impact on the stock’s near-term valuation.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: John Wiley & Sons, Inc. (Wiley) is a global research and learning company that publishes over 1,900 peer-reviewed scientific, technical, medical, and scholarly journals along with academic and professional books, encyclopedias, and digital content .
- 🎯 Current $53.11 is 5% below 3yr high $55.72 · ⏳ SMA200 $39.45 (current price $53.11 is above) · 💰 Market Cap $2.8B
- WLY shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (11.0% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 103% (>20%); ROE 26% (>15%); Low LT D/E 0.81 (<1.0).
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Ancora Advisors LLC Takes $8.72 Million Position in John Wiley & Sons, Inc. — MarketBeat.
🤖 The article says Ancora Advisors built a sizable second-quarter position in WLY and notes continued institutional interest. It also references the company’s dividend increase and consensus Moderate Buy rating, both supportive for the stock.
✅ John Wiley & Sons, Inc. $WLY Shares Acquired by Quantinno Capital Management LP — MarketBeat.
🤖 This piece highlights a large increase in Quantinno Capital Management’s stake in WLY and points to ongoing institutional ownership. It also mentions Wiley’s recent earnings beat and dividend hike, which are constructive signals for the stock.
✅ John Wiley & Sons, Inc. $WLY Shares Purchased by Access Investment Management LLC — MarketBeat.
🤖 The article reports a major increase in Access Investment Management’s position, signaling institutional confidence. It also cites Wiley’s earnings beat and higher dividend, both of which support a positive stock view.
🍭 Bonus (B): 0/10 — Book Publishing

🏢 What they do: Hewlett Packard Enterprise (HPE) is an enterprise technology company that provides compute, storage, networking, and software solutions designed for hybrid IT environments and AI infrastructure.
- 🎯 Current $55.23 is 8% below 3yr high $59.82 · ⏳ SMA200 $31.99 (current price $55.23 is above) · 💰 Market Cap $73.1B
- HPE shows decent technicals supported by positive sentiment.

💎 Quality (Q): 49/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 154% (>20%); Revenue growth 40% (>15%); Low LT D/E 0.86 (<1.0); PEG ratio 0.33 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (12.1%)
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ HPE Named a Leader in 2026 Gartner® Magic Quadrant for Enterprise Storage Platforms — Business Wire.
🤖 HPE said Gartner named it a Leader in enterprise storage platforms, which supports its credibility in storage and AI infrastructure. That kind of recognition can help sentiment by reinforcing product strength and competitive positioning.
✅ HPE Stock Hits a 52-Week High: Is It Too Late to Buy After Morgan Stanley Upgrade? — Yahoo Finance.
🤖 The article highlights Morgan Stanley’s upgrade to Overweight and a higher price target, reflecting improving analyst confidence in HPE. It also points to strong year-to-date share performance and demand tied to AI infrastructure.
⚪️ Foyston Gordon & Payne Inc Makes New $3.20 Million Investment in Hewlett Packard Enterprise Company $HPE — MarketBeat.
🤖 This is mostly an institutional ownership update, but it also repeats HPE’s strong quarterly results and favorable analyst backdrop. The stock impact is limited because the article is primarily about fund activity rather than a new operational catalyst.
⚪️ PDT Partners LLC Invests $5.20 Million in Hewlett Packard Enterprise Company $HPE — MarketBeat.
🤖 This piece is mainly about a new stake purchase, though it reiterates HPE’s strong earnings and raised expectations. The news is mildly supportive but not a direct new business or guidance catalyst.
🍭 Bonus (B): 10/10 — Computer & Office Equipment (Technology sector)

🏢 What they do: HF Sinclair Corporation (DINO) is an independent energy company that operates refineries across the mid-continent, Southwest, Rocky Mountain regions, and Pacific Northwest in the United States, producing and marketing gasoline, diesel fuel, jet fuel, renewable diesel, specialty lubricants, chemicals, and asphalt.
- 🎯 Current $96.52 is 1% below 3yr high $97.32 · ⏳ SMA200 $63.62 (current price $96.52 is above) · 💰 Market Cap $21.5B
- DINO shows decent technicals supported by positive sentiment.

💎 Quality (Q): 59/60
- 🏦 Low drawdown (13.4% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 348% (>20%); Revenue growth 53% (>15%); ROE 19% (>15%).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (5.9%)
- 🔔 Strong above EMA50 (13.8%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (mixed coverage).
✅ HF Sinclair (NYSE:DINO) Hits New 12-Month High — MarketBeat.
🤖 The article says DINO reached a new 52-week high on August 24, reflecting strong price momentum. It also highlights the recently reported earnings beat and dividend increase, both supportive for the stock.
✅ BlackRock Inc. Makes New $1.29 Billion Investment in HF Sinclair Corporation $DINO — MarketBeat.
🤖 The piece reports a large new BlackRock stake in HF Sinclair, which can be interpreted as a vote of confidence from a major institutional investor. It also reiterates the dividend increase and favorable analyst consensus.
❌ HF Sinclair (NYSE:DINO) Rating Lowered to "Strong Sell" at Freedom Capital — MarketBeat.
🤖 Freedom Capital downgraded HF Sinclair to strong sell, which is a direct negative signal for sentiment. The article still notes strong quarterly results, but the rating cut itself weighs on the stock.
⚪️ HF Sinclair Corporation (NYSE:DINO) Receives Consensus Rating of Hold from Brokerages — MarketBeat.
🤖 The article mainly summarizes analyst coverage, noting a Hold consensus and an average price target near the current trading range. That is informative for valuation but not a strong bullish or bearish catalyst by itself.
🍭 Bonus (B): 0/10 — Pipelines (Except Natural Gas)

🏢 What they do: Five9, Inc. provides cloud contact center software, including its Intelligent CX platform for managing customer interactions across voice and digital channels like chat, email, SMS, and social media. Its products also include AI, automation, analytics, and workforce optimization tools that help businesses run customer service and sales operations.
- 🎯 Current $32.00 is 63% below 3yr high $85.47 · ⏳ SMA200 $20.78 (current price $32.00 is above) · 💰 Market Cap $2.4B
- FIVN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 45/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 300% (>20%); Low LT D/E 0.25 (<1.0); PEG ratio 0.15 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (15.1%)
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ ABS Investment Management LLC Acquires Shares of ... — MarketBeat.
🤖 This is mildly positive because it reports a new institutional purchase of FIVN shares, which can support investor confidence. The article also notes multiple analyst target increases, reinforcing a broadly constructive view on the stock.
✅ Five9 (NASDAQ:FIVN) Price Target Raised to $32.00 at ... — MarketBeat.
🤖 This is positive because Wells Fargo lifted its price target on Five9 to $32 while keeping an equal-weight rating, and the article also cites several other recent target increases. Higher target prices suggest improving expectations for the stock.
✅ Five9, Inc. (NASDAQ:FIVN) Given Average Rating of "Moderate Buy" by Brokerages — MarketBeat.
🤖 This is positive because the article says Five9 carries a Moderate Buy consensus from 18 analysts, with an average target price of $31.50. It also highlights several recent target increases, which supports sentiment even though the stock has already rallied.
🍭 Bonus (B): 10/10 — Computer Processing & Data Prep (Technology sector)

🏢 What they do: DexCom, Inc. is a medical device company that develops and sells continuous glucose monitoring (CGM) systems for people with diabetes. Its products, including the Dexcom G6 and G7, use wearable sensors and mobile apps to track glucose levels in real time and help users manage their blood sugar.
- 🎯 Current $88.96 is 37% below 3yr high $140.45 · ⏳ SMA200 $69.53 (current price $88.96 is above) · 💰 Market Cap $33.6B
- DXCM shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 42% (>20%); ROE 38% (>15%); Low LT D/E 0.00 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 5/20
- 🔔 Strong above EMA50 (10.3%)
- 🔔 VWMA trending up (5 consecutive days)
- ⚠️ RSI reversing from overbought (60) — BEARISH
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive.
✅ DexCom (DXCM) Reaches New 52-Week High — MarketBeat.
🤖 The article says DexCom shares hit a new 52-week high after several analysts raised price targets, which is supportive for the stock. It also cites strong quarterly results with EPS and revenue both beating expectations.
✅ DexCom (NASDAQ:DXCM) Reaches New 52-Week High After Analyst Upgrade — MarketBeat.
🤖 RBC raised its price target and maintained an outperform rating, and the stock moved to a new 52-week high. The article also references DexCom’s earnings beat and raised outlook, both favorable for sentiment.
⚪️ Commerce Bank Makes New $1.42 Million Investment in DexCom, Inc. — MarketBeat.
🤖 This is primarily an institutional ownership update, but it includes supportive context from DexCom’s recent earnings beat and the stock’s strong analyst backdrop. The direct news itself is not a major fundamental catalyst, so the impact is mixed to neutral.
🍭 Bonus (B): 0/10 — Surgical & Medical Instruments